Press Releases

Press Releases

Date Title  
Dec 21, 2012
Prothena Begins Trading on NASDAQ Global Market Under Symbol "PRTA"
Company Completes Successful Separation and Share Distribution From Elan
Nov 13, 2012
Prothena to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Prothena to Present at the Lazard Capital Markets 9th Annual Healthcare Conference South San Francisco, CA, November 13, 2012 – Prothena Corporation, a biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, today
Aug 13, 2012
Elan Announces Plan to Spin-Off Discovery Science And Neotope Biosciences to Shareholders
Elan Announces Plan to Spin-Off Discovery Science And Neotope Biosciences to Shareholders Creates two independent, unique companies Transaction aligns assets, timelines, and risk/reward Elan to become immediately profitable and a high growth company Targeting $1.00 earnings per share by 2015 with